Jump to navigation
In the last 20 years, the decision-making process of the entire thoracic oncology community has been influenced by several windstorms that profoundly modified our diagnostic and therapeutic strategies.
Our annual meeting, the IASLC 19th World Conference on Lung Cancer (WCLC 2018), is quickly approaching
Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
By 2030, the number of deaths attributed to lung cancer is expected to double for Latin American women and increase by 50% for men.
Newer treatment options, biomarker-based patient segmentation and the availability of biomarker-based treatment approaches have added to treatment complexity over the years.
The International Association for the Study of Lung Cancer (IASLC) announces a significant jump in the 2017 Impact Factor of the Journal of Thoracic Oncology (JTO) to 10.336, up from 6.595 in 2016.
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces.
Visit theWCLC Virtual Library